Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 15
180
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Two new acetoisovanillone glycosides from the water-soluble fraction of Paeonia ostii

, , , , , , & show all
Pages 2564-2568 | Received 15 Sep 2019, Accepted 26 Oct 2019, Published online: 10 Nov 2019
 

Abstract

The cortex root of Paeonia ostii, is used as a traditional Chinese medicine for treating female diseases. Phytochemical investigation of the water-soluble fraction of the plant led to the isolation of two new acetoisovanillone glycosides: acetoisovanillone-3-O-β-D-glucopyranoside (1) and 2-hydroxy-acetoisovanillone-3-O-β-D-glucopyranoside (2). Their structures were elucidated by extensive spectroscopic methods.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This project was financially supported by the Open Fund of State Key Laboratory of Phytochemistry and Plant Resources in West China (P2017-KF03) and Anhui Innovative Team from Colleges for Scientific Research’s Platform-The Innovative Team in Researching the Key Technologies concerning the Integration of Processing Chinese Medicine Decoction Pieces in Producing Area; We also thank the analytical group of the State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences and Department of Material Science and Information Technology, Anhui University, for spectra test.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.